Phosphocreatine Promotes Osteoblastic Activities in H 2 O 2 -Induced MC3T3-E1 Cells by Regulating SIRT1/FOXO1/PGC-1α Signaling Pathway.
Level 5 - mechanism / opinion, no new human data
Bench research on a mouse cell line with no human data.
PubMed 33198615 · doi:10.2174/1389201021999201116160247
What was done
The authors investigated the effects of phosphocreatine on MC3T3-E1 pre-osteoblast cells exposed to hydrogen-peroxide-induced oxidative stress. Osteoblastic differentiation was assessed by measuring alkaline phosphatase, Runx2, and the OPG/RANKL ratio. Osteoblast apoptosis was evaluated using Hoechst staining. Intracellular reactive oxygen species, ATP generation, and protein expression levels of SIRT1, FOXO1, and PGC-1α were measured to examine the underlying signaling mechanism.
What was found
The abstract reports no numeric values, effect sizes, or statistical figures. It reports directionally that phosphocreatine increased expression of alkaline phosphatase, Runx2, SIRT1, FOXO1, and PGC-1α, increased the OPG/RANKL ratio and ATP production, and suppressed both reactive oxygen species over-generation and apoptosis in hydrogen-peroxide-treated cells.
Why it matters
This paper identifies a potential cellular mechanism involving SIRT1/FOXO1/PGC-1α pathway regulation and ATP preservation through which phosphocreatine protects osteoblasts against oxidative damage.
Limits
The study was conducted entirely in vitro on a murine cell line subjected to acute chemical oxidative stress, which cannot establish clinical efficacy or safety in human osteoporosis. The abstract does not report quantitative data, sample sizes, replicate numbers, or dosing parameters.
Cited by
- context In vitro studies demonstrate that osteoblasts release the cytokine osteoprotegerin in the presence of creatine.